Sri Krishna Pharmaceuticals Ltd. (SKPL), founded in 1974 and based in Hyderabad, India, is a vertically integrated bulk manufacturer of Active Pharmaceutical Ingredients (APIs), Direct Compression (DC) granules, and finished dosage forms. Starting with Paracetamol production for the Indian market, SKPL has grown into a global supplier of various first-line drugs, including Ibuprofen, Metformin, and Aspirin, with five manufacturing facilities and regulatory approvals from bodies like the USFDA and EDQM. The company emphasizes quality, trust, and reliability, serving over 60 global markets and expanding into nutraceuticals through its investments in R&D and technology.